Ravneesh Sachdev
Private Equity Investor at ACCELERON PHARMA INC.
Network origin in Ravneesh Sachdev first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Apple Tree venture Managemnet Llc//vc
 Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge.
24
| Private Company | Investment Managers | 24 |
| Subsidiary | Biotechnology | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Ravneesh Sachdev via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| CELGENE | Biotechnology | Corporate Officer/Principal | |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BCL INDUSTRIES LIMITED | Food: Major Diversified | Chief Operating Officer | |
| AILERON THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Founder | |
| E-THERAPEUTICS PLC | Biotechnology | Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree Graduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Doctorate Degree | |
| Stanford University | College/University | Doctorate Degree Undergraduate Degree | |
Oak Investment Partners
 Oak Investment Partners Investment ManagersFinance Oak Investment Partners (Oak Investment Partners) is a venture capital firm founded in 1978 by Ed F Glassmeyer and Stewart H Greenfield. The firm is headquartered in Wilton, Connecticut. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
Leerink Partners LLC
 Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
| Yale University | College/University | Graduate Degree | |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | College/University | Undergraduate Degree Undergraduate Degree | |
| Princeton University | College/University | Undergraduate Degree Graduate Degree | |
| University of New Brunswick | College/University | Doctorate Degree | |
| Moscow State University Lomonosov | College/University | Graduate Degree | |
| University College London | College/University | Doctorate Degree | |
| Chaudhary Charan Singh University | College/University | Graduate Degree | |
The McKnight Endowment Fund for Neuroscience
 The McKnight Endowment Fund for Neuroscience Investment Trusts/Mutual FundsMiscellaneous The McKnight Endowment Fund for Neuroscience operates as a philanthropic organization. Its services include grantmaking, coalition-building and encouragement of strategic policy reforms. The company was founded by William L. McKnight in 1989 and is headquartered in Minneapolis, MN. | Investment Trusts/Mutual Funds | Director/Board Member | |
| GLOBUS SPIRITS LIMITED | Beverages: Alcoholic | Corporate Officer/Principal | |
| URALKALI | Chemicals: Agricultural | Investor Relations Contact | |
| The Christie NHS Foundation Trust | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Strategic Development Group, Inc.
 Strategic Development Group, Inc. Miscellaneous Commercial ServicesCommercial Services Strategic Development Group, Inc. provides site selection and consulting services. It also offers headquarter site analysis and selection; incentive analysis and negotiation; and post location follow up. The company was founded by Mark Williams and is headquartered in Columbia, SC. | Miscellaneous Commercial Services | Private Equity Investor | |
| The Johns Hopkins University School of Medicine | College/University | Doctorate Degree | |
| Mahatma Jyotiba Phule Rohilkhand University | College/University | Undergraduate Degree | |
| BRAEBURN INC. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member Private Equity Investor | |
Gala Therapeutics, Inc.
 Gala Therapeutics, Inc. BiotechnologyHealth Technology Gala Therapeutics, Inc. engages in biotech and pharma products. The company was founded in October 2015 by Jonathan Reuben Waldstreicher and is headquartered in San Carlos, CA. | Biotechnology | Director/Board Member Founder | |
Tusker Medical, Inc.
 Tusker Medical, Inc. Medical SpecialtiesHealth Technology Tusker Medical, Inc. engages in the development of medical devices for ear, nose, and throat treatments. It offers iontophoresis system and tube delivery system. The company is headquartered in Menlo Park, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member Director/Board Member | |
Marengo Therapeutics, Inc.
 Marengo Therapeutics, Inc. BiotechnologyHealth Technology Marengo Therapeutics, Inc. operates as a biotechnology company that develops immunotherapies. Its product is Universal Targeted Immunotherapy a drug discovery platform that underpins an immunological tumor elimination. The company was founded by Andreas Loew and is headquartered in Cambridge, MA. | Biotechnology | Chairman Director/Board Member Director/Board Member Corporate Officer/Principal | |
Limelight Bio, Inc.
 Limelight Bio, Inc. BiotechnologyHealth Technology Limelight Bio, Inc. engages in the development of proprietary technologies, advanced targets, and drug candidates for the expansion of current gene therapy and gene editing approaches. The company was founded by Phil Johnson and Jean Bennett in 2017 and is headquartered in Philadelphia, PA. | Biotechnology | Chairman Chief Executive Officer | |
Galaxy Medical, Inc.
 Galaxy Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Galaxy Medical, Inc. provides biotechnology services. The company is headquartered in Menlo Park, CA. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
Galvanize Therapeutics, Inc.
 Galvanize Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Galvanize Therapeutics, Inc. operates as a biotechnology firm. The company was founded in 2020 and is headquartered in Redwood City, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chief Executive Officer | |
Galavant Therapeutics, Inc.
 Galavant Therapeutics, Inc. BiotechnologyHealth Technology Galavant Therapeutics, Inc. operates a biotechnology firm. The company is headquartered in Menlo Park, CA. | Biotechnology | Director/Board Member Chief Executive Officer | |
Nine Square Therapeutics, Inc.
 Nine Square Therapeutics, Inc. BiotechnologyHealth Technology Nine Square Therapeutics, Inc. provides biotechnology services. The company was founded in 2020 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member Founder Chief Executive Officer | |
Initial Therapeutics Inc
 Initial Therapeutics Inc BiotechnologyHealth Technology Opal Biosciences, Inc. operates as a biotechnology company. The company is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member Founder | |
Ascidian Therapeutics, Inc.
 Ascidian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ascidian Therapeutics, Inc. operates as a biotechnology research and development company. The company is headquartered in Brighton, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
Nereid Therapeutics, Inc.
 Nereid Therapeutics, Inc. BiotechnologyHealth Technology Nereid Therapeutics, Inc. operates as a life sciences venture firm. It translates the potential of biomolecular condensates into life-changing therapeutics. The company was founded by Clifford Brangwynne and Spiros Liras and is headquartered in Cambridge, MA. | Biotechnology | Chairman Director/Board Member Director/Board Member Director/Board Member | |
Apertor Pharmaceuticals, Inc.
 Apertor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apertor Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is based in Alameda, CA. | Pharmaceuticals: Major | Director/Board Member President Director/Board Member | |
Aulos Bioscience, Inc.
 Aulos Bioscience, Inc. BiotechnologyHealth Technology Aulos Bioscience, Inc. operates as a biotechnology firm. The company is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Chairman | |
Replicate Bioscience, Inc.
 Replicate Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Replicate Bioscience, Inc. is a clinical-stage biopharmaceutical company based in San Diego, CA. The company focuses on creating novel oncology treatments to prevent drug resistance using its synrgy technology. Replicate aims to enhance the effectiveness of many immuno-oncology regimens in early stages of care and is developing its own pipeline of immuno-oncology products in breast, lung, and prostate cancers. Replicate is differentiated by a team of srrna experts, a customizable library of synthetic srrna vectors, and end-to-end development capabilities. The company harnesses the body's natural protein-making power and uses synthetic biology to design unique self-replicating rnas (srrnas) that can direct that power to fight disease. The company was founded by Nathaniel Whang, Zachary Hartman, Michael D. Ehlers, Herbert Kim Lyerly, Andrew J. Geall, and Nathaniel Whang has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Founder | |
| ORGANON & CO. | Pharmaceuticals: Major | Director/Board Member | |
Intergalactic Therapeutics, Inc.
 Intergalactic Therapeutics, Inc. BiotechnologyHealth Technology Intergalactic Therapeutics, Inc. is a gene therapy company based in Baltimore, MD. The company is revolutionizing gene therapies with a novel non-viral platform comprised of its versatile synthetic and episomal c3dna molecules. The company uses a customized approach to focal therapeutic delivery using its lead delivery technology, the comet pulsed electric field system, and a proprietary cell-free manufacturing process invented to make gene therapy safer and more accessible for patients. With programs in ophthalmology, oncology, respiratory diseases, and expansion areas including CNS, renal, and musculoskeletal, Intergalactic Therapeutics is dedicated to transforming genetic medicine. The company was founded by Michael D. Ehlers, and Theresa G. H. Heah has been the CEO of the company since 2023. | Biotechnology | Director/Board Member Director/Board Member Founder | |
Aethon Therapeutics, Inc.
 Aethon Therapeutics, Inc. Hospital/Nursing ManagementHealth Services The company, co-founded by venture capital firm Apple Tree Partners and New York University cancer researchers Shohei Koide, Ph.D., and Benjamin G. Neel, Ph.D., unites immunotherapy and targeted therapy to expand the power and promise of both approaches for people living with cancer. Aethon Therapeutics, Inc. is based in New York, NY. Part of NYU Langone Medical Center, Aethon Therapeutics, Inc. is a company that creates neoantigens by design to transform cancer treatments into cures. The company's novel anti-drug-peptide conjugate/mhc antibodies are designed to be used in combination with targeted covalent inhibitors of ras, egfr, and other oncogenic driver mutations to mount immune attacks and selectively kill residual cancer cells, including drug-resistant "persister" cells. The company was founded by Benjamin G. Neel, Shohei Koide. The CEO is Rajesh Chopra. | Hospital/Nursing Management | Chairman Chief Executive Officer Director/Board Member |
Statistics
International
| United States | 39 |
| United Kingdom | 5 |
| India | 5 |
| Russia | 3 |
| Canada | 2 |
Sectoral
| Health Technology | 24 |
| Consumer Services | 13 |
| Commercial Services | 7 |
| Consumer Non-Durables | 3 |
| Finance | 3 |
Operational
| Director/Board Member | 101 |
| Corporate Officer/Principal | 47 |
| Founder | 28 |
| Chairman | 27 |
| Undergraduate Degree | 21 |
Most connected contacts
| Insiders | |
|---|---|
| Seth Harrison | 43 |
| Argeris Karabelas | 42 |
| Anna Batarina | 15 |
| Michael Ehlers | 15 |
| Matthew Osborne | 14 |
| Joseph Yanchik | 13 |
| Matthew Jacobson | 12 |
| Jonathan Waldstreicher | 11 |
| Rajesh Chopra | 10 |
| Spiros Liras | 10 |
| Paul Eisenberg | 9 |
| Vern Norviel | 8 |
| Ravindra Kumar | 8 |
| William Engels | 7 |
| Raj Mehta | 6 |
- Stock Market
- Insiders
- Ravneesh Sachdev
- Company connections
